SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 111 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $412,000 | -56.3% | 24,247 | -61.5% | 0.01% | -50.0% |
| Q3 2017 | $943,000 | +110.5% | 63,040 | -18.6% | 0.02% | +20.0% |
| Q2 2016 | $448,000 | -82.1% | 77,442 | -81.3% | 0.02% | -78.9% |
| Q1 2016 | $2,500,000 | -38.2% | 413,144 | -6.4% | 0.07% | -25.3% |
| Q4 2015 | $4,045,000 | +225.7% | 441,284 | +100.4% | 0.10% | +143.6% |
| Q3 2015 | $1,242,000 | -36.8% | 220,164 | +24.2% | 0.04% | -26.4% |
| Q2 2015 | $1,966,000 | -8.3% | 177,308 | +29.7% | 0.05% | -3.6% |
| Q1 2015 | $2,143,000 | -37.1% | 136,692 | -40.4% | 0.06% | -26.7% |
| Q4 2014 | $3,408,000 | +141.0% | 229,462 | +75.9% | 0.08% | +134.4% |
| Q3 2014 | $1,414,000 | +128.1% | 130,427 | +64.2% | 0.03% | +88.2% |
| Q2 2013 | $620,000 | – | 79,432 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |